Kolb, E. A., Morton, C., Houghton, P. J., Maris, J. M., Friedman, H. S., Kier, S. T., … Smith, M. A. (2008). 558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12. In European Journal of Cancer Supplements (Vol. 6, pp. 176–176). Elsevier BV. https://doi.org/10.1016/s1359-6349(08)72492-3

Kolb, E. A., C. Morton, P. J. Houghton, J. M. Maris, H. S. Friedman, S. T. Kier, R. G. Gorlick, M. H. Kang, C. P. Reynolds, and M. A. Smith. “558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12.” In European Journal of Cancer Supplements, 6:176–176. Elsevier BV, 2008. https://doi.org/10.1016/s1359-6349(08)72492-3.

Kolb EA, Morton C, Houghton PJ, Maris JM, Friedman HS, Kier ST, et al. 558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12. In: European Journal of Cancer Supplements. Elsevier BV; 2008. p. 176–176.

Kolb, E. A., et al. “558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12.” European Journal of Cancer Supplements, vol. 6, no. 12, Elsevier BV, 2008, pp. 176–176. Crossref, doi:10.1016/s1359-6349(08)72492-3.

Kolb EA, Morton C, Houghton PJ, Maris JM, Friedman HS, Kier ST, Gorlick RG, Kang MH, Reynolds CP, Smith MA. 558 POSTER Pediatric Preclinical Testing Program (PPTP) evaluation of the fully human anti-IGF-1R antibody IMC-A12. European Journal of Cancer Supplements. Elsevier BV; 2008. p. 176–176.